Leveraging HIV treatment to end AIDS, stop new HIV infections, and avoid the cost of inaction

Clinical Infectious Diseases

Volumn 59, Issue SUPPL.1, 2014, Pages

  Sidibé, Michel ^a   Zuniga, José M ^b   Montaner, Julio ^c  

^a UNAIDS   (Switzerland)

^b INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE   (United States)

^c Brit Columbia Ctr Excell HIV/AIDS   (Canada)

Author keywords

antiretroviral therapy; HIV; prevention; testing; treatment

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; ANTIVIRAL THERAPY; ARTICLE; HARM REDUCTION; HEALTH AUXILIARY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HETEROSEXUALITY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INVESTMENT; LOWEST INCOME GROUP; MORBIDITY; MORTALITY; PATIENT COUNSELING; PRIORITY JOURNAL; RESOURCE ALLOCATION; SCALE UP; TREATMENT OUTCOME; VIRUS LOAD; ACQUIRED IMMUNODEFICIENCY SYNDROME; ECONOMICS; HIV INFECTIONS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS;

EID: 84904814169     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu321     Document Type: Article

References (14)

1. Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013; 8:e81355.
2. Karim SAS, Karim QA. Antiretroviral prophylaxis: a defining moment in HIV control. Lancet 2011; 378:e23-5.
3. Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and metaanalysis. AIDS 2009; 23:1397-404.
4. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2003; 342:921-9.
5. Montaner JS, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006; 368:531-6. (Pubitemid 44142776)
6. Tanser F, Bärnighausen T, Grapsa E, et al. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013; 339:966-71.
7. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva, Switzerland: WHO, 2013.
8. United Nations Joint Programme on HIV/AIDS. AIDS by the numbers. Geneva, Switzerland: UNAIDS, 2013.
9. United Nations Joint Programme on HIV/AIDS. Treatment 2015. Geneva, Switzerland: UNAIDS, 2013.
10. World Health Organization/United Nations Joint Programme on HIV/AIDS/United Nations Children's Fund. Global update on HIV treatment 2013: results, impact, and opportunities. Geneva, Switzerland: WHO, UNAIDS, UNICEF, 2013.
11. Lima VD, Johnston K, Hogg RS, et al. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis 2008; 198:59-67. (Pubitemid 351920290)
12. United Nations Joint Programme on HIV/AIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. Geneva, Switzerland: UNAIDS, 2013.
13. Baer B, Ball A, Nygren-Krug H, et al. Human rights-based approaches to HIV, tuberculosis, and malaria. In: Zuniga JM, Marks SP, Gostin LO, eds. Advancing the Human Right to Health. Oxford, UK: Oxford University Press, 2013: 245-58.
14. United Nations Joint Programme on HIV/AIDS. Smart investments. Geneva, Switzerland: UNAIDS, 2013.